ArticleActa physiologica (Oxford, England)2022
The prolyl hydroxylase inhibitor molidustat fails to restore erythropoietin production in the fibrotic kidney.
Gunnar Schley et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it